ENDRA Life Sciences Inc. Common Stock
Market Cap
9.3M
Short interest (May 15)
2.6%
Net Short (Jun 03 ): -0.1%
Borrow Fee
8.18%
↓ 13.6%
Available Shares
100K
↑ 20.0%
Price Chart
Company Overview
ENDRA Life Sciences Inc is engaged in the development of thermo-acoustic enhanced ultrasound (TAEUS) technology to improve the capabilities of clinical diagnostic ultrasound. The company's technology is used to measure tissue composition, including the assessment of fat in the liver, and is being developed for additional clinical applications such as tissue temperature monitoring.
Company Info
Market Data
Short Interest
Recent Changes
Quick Actions
Investment Risk
This is not financial advice. All investments carry risk. Do your own research before making investment decisions.